Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

From blood and spinal fluid to skin – insights into different biomarkers for MND

Original source

From blood and spinal fluid to skin – insights into different biomarkers for MNDMotor Neurone Disease Association (UK) · 6 December 2025 (opens in a new tab)

Related topics

Abnormal TDP-43 clumps were found in skin samples from 17 people who were symptom-free at the time and later developed motor neurone disease (MND). The highest levels were found in sweat glands from the shoulder and back. Researchers are investigating whether skin could provide a minimally invasive biomarker before symptoms begin.

Why this matters

A skin-based biomarker could eventually help researchers identify MND-related changes before neurological symptoms appear. This early finding does not currently change diagnosis or treatment, and further studies are needed to show how reliably the approach works.

Limitations and context

This information comes from an MND Association blog describing a biomarker session, rather than a primary research paper. The reported study included 17 people, and the source does not provide details of a comparison group, testing accuracy or peer review. The finding remains exploratory and would need validation in larger studies.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?